688114.SS
688114.SS
CNE100005PC8
MGI TECH CO LTD
Loading chart...

Company Profile

MGI Tech Co., Ltd. engages in the research, development, production, and sale of instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally. Its products include sequencer products, such as DNBSEQ sequencers, cycloneSEQ sequencers, and sequencing consumables; generative lab intelligence, including sample pretreatment, nucleic acid extraction, universal pipetting, consumables, integrated platforms, intelligent digital platform, and sample preparations; and Multi-Omics, such as cell omics, STOmics, preteomics, PopOmics, sample preparation regeants, microbiomics, agriculture and food safety, public health, environment and biodiversity, ultrasound, bio-fragment analyzer, sample storage, and fluorometer products. MGI Tech Co., Ltd. was founded in 2016 and is headquartered in Shenzhen, China.

Related stocks

002223.SZ
002223.SZ • China
YUYUE MEDICAL
26.12 CNY
3.89B USD 1Y -33%
300003.SZ
300003.SZ • China
LEPU MEDICAL
11.68 CNY
3.22B USD 1Y -32.7%
603658.SS
603658.SS • China
AUTOBIO DIAGNOSTICS CO LTD
33.45 CNY
2.86B USD 1Y -14.8%
002901.SZ
002901.SZ • China
DOUBLE MEDICAL
40.08 CNY
2.48B USD 1Y -31.1%
2675.HK
2675.HK • China
EDGE MEDICAL-B
33 HKD
1.64B USD
300529.SZ
300529.SZ • China
JAFRON
15.12 CNY
1.81B USD 1Y -31.8%
688617.SS
688617.SS • China
APT MEDICAL INC
242.85 CNY
5.14B USD 1Y -23.1%
0853.HK
0853.HK • China
MICROPORT
6.08 HKD
1.48B USD 1Y -59%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
57.5% p.a.
Max Drawdown (5Y)
-74.5%
Sharpe Ratio (5Y)
-0.20
Beta Factor
0.29
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Unprofitable business model: The company is currently generating net losses.
🔴 High valuation risk: Avg P/E of 521.4 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (57.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -74.5% in the extended horizon.
ende